https://www.bseindia.com/xml-data/corpfiling/AttachHis/494f205b-5e56-4a8e-a3ca-921d72981df0.pdf
https://www.bseindia.com/xml-data/corpfiling/AttachHis/47ef817f-7f7a-4f05-b43e-9c591c375841.pdf
https://www.prnewswire.com/in/news-releases/bal-pharma-limited-showcased-strong-revenue-growth-for-q3--9mfy23-results-against-adverse-market-conditions-301742796.html
https://www.prnewswire.com/in/news-releases/bal-pharma-limited-announces-resilient-revenue-growth-for-q2-amp-h1fy23-results-against-price-volatility-and-intense-api-competition-894731482.html
http://twofourinsight.com/indian-government-protects-local-pharma-industry-imposes-anti-dumping-duty-on-bulk-imports-from-china-of-gliclazide/
http://www.business-standard.com/article/news-cm/bal-pharma-gains-after-launching-otc-medicine-in-bangalore-115091000209_1.html